Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas.
R Izu-BellosoI Gainza-ApraizP Ortiz-RomeroO Servitje-BedateR Fernández de Misa-CabreraY PeñateB Hernandez-MachinT Estrach-PanellaM Llamas-VelascoJ I Yanguas-BayonaM Morillo-AndujarE Acebo-MariñasS Perez-GalaJ C Armario-HitaP Sanchez-SambucetyA Ortiz-BruguesC Eguren-MichelenaI Bielsa-MarsolA Lopez-PestañaM Blanes-MartinezM Fernandez-GuarinoI Lopez-LermaPublished in: Actas dermo-sifiliograficas (2024)
Our study confirms bexarotene is a safe and effective therapy for the long-term treatment of CTCL.
Keyphrases